W Advisors LLC Buys Shares of 7,622 CVS Health Co. (NYSE:CVS)

W Advisors LLC purchased a new position in shares of CVS Health Co. (NYSE:CVS) in the 2nd quarter, Holdings Channel reports. The firm purchased 7,622 shares of the pharmacy operator’s stock, valued at approximately $450,000.

Several other hedge funds also recently modified their holdings of the company. International Assets Investment Management LLC increased its position in CVS Health by 11.4% in the 4th quarter. International Assets Investment Management LLC now owns 16,744 shares of the pharmacy operator’s stock valued at $1,322,000 after acquiring an additional 1,715 shares during the period. Gryphon Financial Partners LLC raised its position in CVS Health by 48.3% during the 4th quarter. Gryphon Financial Partners LLC now owns 8,151 shares of the pharmacy operator’s stock worth $654,000 after purchasing an additional 2,653 shares during the last quarter. Northwest Financial Advisors bought a new stake in shares of CVS Health in the 4th quarter valued at about $42,000. AGF Management Ltd. increased its stake in shares of CVS Health by 34.6% in the fourth quarter. AGF Management Ltd. now owns 341,619 shares of the pharmacy operator’s stock valued at $26,974,000 after buying an additional 87,766 shares during the period. Finally, Jump Financial LLC raised its position in shares of CVS Health by 27.9% during the fourth quarter. Jump Financial LLC now owns 40,900 shares of the pharmacy operator’s stock worth $3,229,000 after acquiring an additional 8,928 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of recent analyst reports. Baird R W raised shares of CVS Health to a “hold” rating in a research report on Thursday, May 30th. Barclays lowered their target price on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a research note on Thursday, August 8th. JPMorgan Chase & Co. cut their price target on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a research report on Thursday, May 30th. Deutsche Bank Aktiengesellschaft lowered their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Finally, Evercore ISI decreased their target price on CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Eleven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $72.48.

CVS Health Trading Down 0.6 %

NYSE CVS opened at $57.75 on Friday. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $72.50 billion, a P/E ratio of 10.15, a PEG ratio of 0.80 and a beta of 0.53. The business has a fifty day simple moving average of $58.29 and a 200 day simple moving average of $63.78. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same period last year, the firm earned $2.21 earnings per share. The firm’s revenue was up 2.6% on a year-over-year basis. On average, analysts predict that CVS Health Co. will post 6.52 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.61%. The ex-dividend date was Monday, July 22nd. CVS Health’s payout ratio is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.